Ankyrbio LLC

Vivasc Therapeutics Inc., based in Pittsburgh, PA, specializes in innovative drug delivery systems focused on reversing the effects of heart failure and treating atrial fibrillation. Utilizing their proprietary Cardiac Targeting Peptide, they aim to deliver therapeutic agents specifically to cardiomyocytes, addressing underlying cellular dysfunction rather than merely alleviating symptoms associated with heart diseases. Founded in 2020, the company has engaged in several STTR Phase I projects, demonstrating significant advancements in delivery methods for treatment options like miRNA and amiodarone, designed to target heart tissues with precision. Their research holds promise for improving patient outcomes by mitigating adverse effects commonly related to current heart failure and arrhythmia treatments. Generated from the website

Peptilogics is a Pittsburgh-based company that aims to revolutionize the discovery process for novel peptide therapeutics, focusing on patients with serious and life-threatening diseases. By combining the untapped potential of peptide biology with the power of machine learning, Peptilogics utilizes precision engineering and design to create the next generation of medicines at a massive scale. With their AI platform, Peptilogics is able to transform peptide drug discovery by leveraging advancements in AI algorithms, supercomputing, and peptide R&D. Their approach efficiently accesses new functional chemical space to design peptides with optimized properties for success as drug candidates, targeting serious conditions with high unmet medical needs and accelerating discovery efforts previously deemed impossible.Generated from the website

Noveome Biotherapeutics, Inc. is a pioneering biotechnology company based in Pittsburgh, PA, dedicated to advancing the field of regenerative medicine. Their groundbreaking ST266 biologic, a multi-targeted secretome containing numerous biologically active proteins and factors crucial to healing, holds significant clinical potential for a range of underserved conditions in ophthalmology, neurology, dermatology, and beyond. With a focus on innovative delivery options and scalable manufacturing, Noveome is committed to developing effective treatments that simulate natural healing processes. Their portfolio covers important ophthalmic indications, and their passionate and diverse team is dedicated to making a positive difference in patients' lives.Generated from the website